Estland -
estniska -
Ravimiamet
farpenta suus dispergeeruv tablett
rivopharm limited - olansapiin - suus dispergeeruv tablett - 5mg 30tk; 5mg 98tk; 5mg 56tk; 5mg 28tk
Estland -
estniska -
Ravimiamet
farpenta õhukese polümeerikattega tablett
rivopharm limited - olansapiin - õhukese polümeerikattega tablett - 15mg 98tk; 15mg 30tk; 15mg 28tk
Estland -
estniska -
Ravimiamet
farpenta õhukese polümeerikattega tablett
rivopharm limited - olansapiin - õhukese polümeerikattega tablett - 20mg 28tk; 20mg 30tk; 20mg 98tk
Estland -
estniska -
Ravimiamet
farpenta suus dispergeeruv tablett
rivopharm limited - olansapiin - suus dispergeeruv tablett - 20mg 28tk; 20mg 98tk
Estland -
estniska -
Ravimiamet
onelar gastroresistentne kõvakapsel
medochemie limited - duloksetiin - gastroresistentne kõvakapsel - 60mg 56tk; 60mg 500tk; 60mg 28tk; 60mg 100tk; 60mg 196tk; 60mg 140tk; 60mg 7tk; 60mg 30tk
Europeiska unionen -
estniska -
EMA (European Medicines Agency)
trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastilised ained - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.
Estland -
estniska -
Adama
agil® 100 ec
adama - emulsioonikontsentraat - propakvisafop - herbitsiidid
Estland -
estniska -
Adama
legacy® 500 sc
adama - suspensioonikontsentraat - diflufenikaan - herbitsiidid